You are viewing a free summary from Descrybe.ai. For citation checking, legal issue analysis, and other advanced tools, explore our Legal Research Toolkit — not free, but close.

Christiansen v. Wright Medical Technology Inc.

Citations: 127 F. Supp. 3d 1306; 98 Fed. R. Serv. 466; 2015 U.S. Dist. LEXIS 115601; 2015 WL 5117896Docket: MDL Docket No. 2329; No. 1:13-cv-297-WSD

Court: District Court, N.D. Georgia; August 31, 2015; Federal District Court

Narrative Opinion Summary

This case involves litigation centralized under MDL 1:12-md-2329 concerning alleged defects in Wright Medical Technology's Conserve hip implant system. The plaintiff, who experienced implant failure and subsequent health issues, asserts claims against Wright Medical entities for strict product liability, negligence, and fraudulent misrepresentation. The litigation's procedural history includes motions to exclude expert testimony under the Daubert standard and motions for summary judgment. The court evaluated the admissibility of expert opinions on metallosis, emphasizing the reliability of methodologies used by experts. The defendants sought summary judgment, arguing lack of personal jurisdiction and insufficient evidence of liability. They also claimed preemption under the Medical Device Amendment and invoked the learned intermediary doctrine to counter failure to warn claims. However, the court found genuine disputes of material fact precluding summary judgment on most claims, rejecting the preemption defense due to the lack of FDA premarket approval for the specific implant system in question. The court dismissed failure to warn claims based on the learned intermediary doctrine, as the prescribing physician did not rely on product warnings. The plaintiff's claims for punitive damages and other tort-based allegations were allowed to proceed, while summary judgment was granted concerning prejudgment interest and certain expert testimonies.

Legal Issues Addressed

Comment K of Restatement (Second) of Torts Section 402A

Application: The court found Comment K did not apply to the Conserve implant, as there were disputed facts about its safety and marketing, preventing summary judgment for the defendants.

Reasoning: The case record reveals disputed material facts about the safety and marketing of the Conserve implant, preventing the court from granting summary judgment based on Comment K.

Daubert Standard for Expert Testimony

Application: The court evaluated the admissibility of expert testimony on metallosis under the Daubert standard, focusing on the expert's qualifications and the reliability and relevance of their methodology.

Reasoning: The admissibility of expert opinions is governed by Federal Rules of Evidence 702 and 703... The Daubert standard, as established in Daubert v. Merrell Dow Pharmaceuticals, Inc., further outlines criteria for the admissibility of expert testimony...

Learned Intermediary Doctrine

Application: The court applied the learned intermediary doctrine to dismiss the plaintiff's failure to warn claims, noting that the prescribing physician did not read the provided warnings.

Reasoning: The defendants argue that the facts do not support a failure to warn claim because Rasmussen did not read any warnings, which negates proximate cause.

Multidistrict Litigation Centralization

Application: The Judicial Panel on Multidistrict Litigation centralized lawsuits concerning defects in Wright Medical's Conserve hip implant products into MDL 1:12-md-2329 for coordinated pretrial proceedings.

Reasoning: On February 27, 2012, the United States Judicial Panel on Multidistrict Litigation centralized five lawsuits concerning defects in Wright Medical Technology Inc.’s Conserve hip implant products, identified as MDL 1:12-md-2329.

Preemption under the Medical Device Amendment

Application: The court rejected the defendants' preemption defense, ruling that the Conserve Hip Implant System did not receive FDA premarket approval, thus not qualifying for preemption under the MDA.

Reasoning: The defendants acknowledge that the Conserve Hip Implant System itself was not premarket approved by the FDA...

Rule 703 of the Federal Rules of Evidence

Application: The court allowed plaintiff's experts to rely on Dr. Rasmussen's observations regarding metallosis under Rule 703, finding such reliance reasonable in the medical community.

Reasoning: The Court found that under Rule 703 of the Federal Rules of Evidence, Plaintiff's experts can rely on Rasmussen’s insights, regardless of their admissibility, as long as such reliance is reasonable within the medical community.

Summary Judgment Standards

Application: The court denied summary judgment for the defendants on most claims due to the presence of genuine disputes of material fact, particularly regarding the defendants' involvement in the design and marketing of the implant.

Reasoning: WMG is denied summary judgment due to a lack of admissible evidence proving its non-involvement in the design, manufacture, sale, or marketing of the Conserve hip implant components.